June 24, 2022
Paragon and its portfolio companies continue to [...]
May 25, 2022
– Funding expected to provide sufficient capital [...]
April 5, 2022
Expansion builds on initial strategic collaboration and [...]
March 1, 2022
License agreement secures potential research of ecopipam for [...]
December 16, 2021
Chicago, Dec. 16, 2021 – Paragon Biosciences has [...]
December 7, 2021
Chicago, Dec. 7, 2021 – Paragon Biosciences [...]
November 10, 2021
Statistically significant, clinically meaningful results obtained on the [...]
September 14, 2021
Current enrollment for stuttering study is at 75%; [...]